Interleukin (IL-)15 has less activity than IL-2 to promote type 2 cytokine predominance in tumour-associated mononuclear cells from lung cancer patients

Cytokine

Volumn 13, Issue 2, 2001, Pages 119-123

  Takeuchi, Eiji ^a   Yanagawa, Hiroaki ^a   Suzuki, Yoshihiro ^a   Shinkawa, Kunihiro ^a   Bando, Hiroyasu ^b   Sone, Saburo ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL KILLING; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0035924917     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0808     Document Type: Article

References (15)

1. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes
2. Interleukin-15 and the growth of tumor derived activated T-cells
3. Lymphocyte responses and cytokines
4. Presence and potent immunosuppressive role of interleukin-10 in malignant pleural effusion due to lung cancer
5. Local expression of antiinflammatory cytokines in cancer
6. Comparative analysis of interleukin-15 and interleukin-2 for induction of killer activity and type 2 cytokine production by mononuclear cells from lung cancer patients
7. Eosinophil colony-stimulating factor induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy
8. In vivo production of interleukin-5, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients
9. Adoptive immunotherapy with highdose interleukin-2: Kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level
10. + T cells for IFN-γ but have differential effects on priming for IL-4
11. The expanding universe of T-cell subsets: Th1, Th2 and more
12. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens
13. Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms
14. Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusions
15. Contrasting effect of interleukin-13 on interleukin-1 receptor antagonist and proinflammatory cytokine production by human alveolar macrophages